EPIAO (Recombinant human erythropoietin (rhEPO)) eShow Global
EPIAO (Recombinant human erythropoietin (rhEPO))

沈阳三生制药有限责任公司

Shenyang Sunshine Pharmaceutical Co. Ltd.,

China    City:Shenyang

Contact information
Visible after login
Product Promotion Page
Comment
Product Details

In 1998, EPIAO was marketed with approval of the CFDA, which was the first rhEPO products marketed in China. Since 2002, it has been the leading brand of China’s erythropoin market. It is included in the National Medical Insurance Catalogue as a Category B drug.

Comment
Comment